ProQR Therapeutics NV (PRQR)
2.365
-0.06
(-2.67%)
USD |
NASDAQ |
Aug 25, 16:00
2.365
0.00 (0.00%)
After-Hours: 18:59
ProQR Therapeutics Gross Profit Margin (Quarterly) : 91.93% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.93% |
| March 31, 2026 | 65.86% |
| December 31, 2025 | 85.52% |
| September 30, 2025 | 76.72% |
| June 30, 2025 | 82.32% |
| March 31, 2025 | 85.00% |
| December 31, 2024 | 84.42% |
| September 30, 2024 | 82.10% |
| June 30, 2024 | 88.72% |
| March 31, 2024 | 84.47% |
| December 31, 2023 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 10.27% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pharming Group NV | 80.56% |
| NewAmsterdam Pharma Co. NV | 98.41% |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | 82.65% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.59% |
| Return on Assets | -34.70% |
| Return on Invested Capital | -58.40% |
| Profit Margin (Quarterly) | -99.65% |
| Operating Margin (Quarterly) | -100.7% |
| Return on Net Operating Assets | -264.9% |